Evidence map›Paper›PMID 37366394›Full record

ArticleEngineering applications of artificial intelligence2023

Feature-based deep neural network approach for predicting mortality risk in patients with COVID-19.

Thing-Yuan Chang, Cheng-Kui Huang, Cheng-Hsiung Weng, Jing-Yuan Chen

Abstract read
In one paragraph

Article in Engineering applications of artificial intelligence, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Thing-Yuan ChangDepartment of Information Management, National Chin-Yi University of Technology, Taichung 41130, Taiwan, Republic of China.
Cheng-Kui HuangDepartment of Business Administration, National Chung Cheng University, 168, University Rd., Min-Hsiung, Chia-Yi, Taiwan, Republic of China.
Cheng-Hsiung WengDepartment of Information Management, National Chin-Yi University of Technology, Taichung 41130, Taiwan, Republic of China.
Jing-Yuan ChenDepartment of Information Management, National Chin-Yi University of Technology, Taichung 41130, Taiwan, Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we integrate deep neural network (DNN) with hybrid approaches (feature selection and instance clustering) to build prediction models for predicting mortality risk in patients with COVID-19. Besides, we use cross-validation methods to evaluate the performance of these prediction models, including feature based DNN, cluster-based DNN, DNN, and neural network (multi-layer perceptron). The COVID-19 dataset with 12,020 instances and 10 cross-validation methods are used to evaluate the prediction models. The experimental results showed that the proposed feature based DNN model, holding Recall (98.62%), F1-score (91.99%), Accuracy (91.41%), and False Negative Rate (1.38%), outperforms than original prediction model (neural network) in the prediction performance. Furthermore, the proposed approach uses the Top 5 features to build a DNN prediction model with high prediction performance, exhibiting the well prediction as the model built by all features (57 features). The novelty of this study is that we integrate feature selection, instance clustering, and DNN techniques to improve prediction performance. Moreover, the proposed approach which is built with fewer features performs much better than the original prediction models in many metrics and can still remain high prediction performance.

Indexed as

COVID-19Deep learningFeature-based DNNFeature selectionMortality risk

Identifiers

PMID37366394
PMCPMC10277846

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.